Rheumatology Advance Access published online on January 6, 2004
Rheumatology, doi:10.1093/rheumatology/keh073
Rheumatology © British Society for Rheumatology 2004; all rights reserved
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Original Papers
1 Rheumatology Unit, Department of Medicine, Karolinska Hospital, Stockholm, Sweden
* Corresponding author. E-mail: esbjorn.larsson{at}ks.se.
Received 23 June 2003
; accepted 13 July 2003
Objective. To examine if changes in serum cartilage oligomeric matrix protein (COMP) correlate with the development of cartilage damage, as measured by histological grading, in corticosteroid-treated animals with collagen-induced arthritis (CIA). Methods. DA rats with established CIA were treated with corticosteroids (betamethasone, 0.1 mg/kg body weight) or placebo (saline) intraperitoneally once daily after reaching an arthritis score exceeding 1. The treatment continued throughout the study. Arthritis progression was monitored by clinical scoring of paws, serial measurements of serum COMP and fibrinogen, and histological grading of paws. Results. Corticosteroid treatment reduced clinical signs of arthritis compared with placebo (arthritis score reduced, P < 0.01 at day 25). Corticosteroid treatment also reduced fibrinogen levels compared with placebo (P < 0.01). The morphological changes in the joint were less severe in the corticosteroid-treated animals (median cartilage score 4 in the placebo group, 0 in the corticosteroid-treated group; P < 0.01). The levels of COMP remained unchanged during treatment in the corticosteroid-treated arthritic animals, whereas an increase in levels of COMP was observed in rats treated with placebo (P < 0.01). There was a correlation between serum COMP and the extent of cartilage destruction at day 25 after immunization (r = 0.77, P < 0.001). Conclusions. Corticosteroids given therapeutically to arthritic rats diminish joint destruction histologically, and stable serum COMP levels reflect this effect.
Key words: Collagen-induced arthritis, Cartilage oligomeric matrix protein (COMP), Fibrinogen, Corticosteroids.
Corticosteroid treatment of experimental arthritis retards cartilage destruction as determined by histology and serum COMP
2 Department of Clinical Chemistry, University Hospital, Uppsala, Sweden
3 Department of Rheumatology and Department of Cell and Molecular Biology, Lund University, Lund, Sweden
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  B. BJORNHART, A. JUUL, S. NIELSEN, M. ZAK, P. SVENNINGSEN, and K. MULLER Cartilage Oligomeric Matrix Protein in Patients with Juvenile Idiopathic Arthritis: Relation to Growth and Disease Activity J Rheumatol, August 1, 2009; 36(8): 1749 - 1754. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z N Jahangier, K M G Jacobs, J W J Bijlsma, and F P J G Lafeber Radiation synovectomy with yttrium-90 for persisting arthritis has direct harmful effects on human cartilage that cannot be prevented by co-administration of glucocorticoids: an in vitro study Ann Rheum Dis, October 1, 2006; 65(10): 1384 - 1389. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Bileviciute-Ljungar, T. Saxne, and M. Spetea Anti-inflammatory effects of contralateral administration of the {kappa}-opioid agonist U-50,488H in rats with unilaterally induced adjuvant arthritis Rheumatology, March 1, 2006; 45(3): 295 - 302. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. E. Godler, A. N. Stein, O. Bakharevski, M. M. L. Lindsay, and P. F. J. Ryan Parathyroid hormone-related peptide expression in rat collagen-induced arthritis Rheumatology, September 1, 2005; 44(9): 1122 - 1131. [Abstract] [Full Text] [PDF]
|
|